Skip to main content
. 2021 May 29;12(2):346–355. doi: 10.34172/apb.2022.033

Figure 3.

Figure 3

The in vitro antibacterial efficacy of non-crosslinked (FZ-A, FZ-P) and crosslinked (FZ-AG, FZ-PG) nanofibers against S. aureus (A) and E. coli (B). (C) The microbial assay plates cultured to quantify drug in samples collected from rabbits’ tear fluid following the administration of FZ-AG samples.”